Company Intelligence

NeuroX1

Computational drug discovery leveraging generative AI to create therapeutics for neurodegenerative disorders.

In this profile

Quick Facts

  • Founded 2024
  • Headquarters Austin, Americas
  • Country Americas
  • Industry AI in Enterprise Software
  • Company Type Techstars Industries of the Future Accelerator
  • Status Active
  • Website Official site
  • Last Reviewed Aug 2026

Executive Summary

Computational drug discovery leveraging generative AI to create therapeutics for neurodegenerative disorders.

Why It Matters

NeuroX1 appears in the public Techstars Industries of the Future Accelerator portfolio (open accelerator dataset).

Recent Developments

  1. 2024 Company founded

    NeuroX1 was founded in 2024 per the company profile source on file.

    Source

Connected Reports

Connected Insights

Industries

Computational drug discovery leveraging generative AI to create therapeutics for neurodegenerative disorders.

Company information is based on publicly available sources and is reviewed periodically. If you represent this company and would like to request a correction, contact Brel.

Explore Related Intelligence

The AI Brief

Weekly company intelligence in your inbox.

Subscribe